MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/ta.0000000000005054

Медицинская библиотека · The journal of trauma and acute care surgery · 2026

The intravenous targeted nanopeptide, CAQK, is neuroprotective and improves motor function after spinal cord injury in rats.

Castillo Jose A, Uppuluri Jay, Le Michael, Tran Taylor, Pivetti Christopher, Huang Kuan-Wei, Vatoofy Sina, Ratcliff Amanda, Dangan Andrei, Bannerman Solomon, Lee Maya, Shahin Mehrad, Loll Emma, Clark Kaitlin, Wang Aijun, Russo Rachel

СтатьяПеревод в очереди

Аннотация

BACKGROUND

CAQK is a homing peptide that targets sites of central nervous system injury and has previously demonstrated functional benefits in traumatic brain injury models. We recently demonstrated its localization to spinal cord injury (SCI) after intravenous administration and hypothesized that it could enhance motor recovery after SCI.

METHODS

Twelve female Sprague-Dawley rats underwent C5 right-sided spinal cord hemicontusion. Animals were randomized to receive intravenous CAQK (2.5 mg/kg) or saline daily for 7 days, beginning 1 hour postinjury. Motor performance was assessed using the Irvine, Beatties, and Bresnahan (IBB) Forelimb Recovery Scale, a scale from 0 to 9, with 9 being normal function. IBB score was assessed at five time points over 8 weeks, followed by histological analysis. An in vitro neuroprotection assay was also conducted to evaluate the neuroprotective effects of CAQK at various doses.

RESULTS

All animals exhibited motor deficits immediately after injury. Compared with saline controls, CAQK-treated rats demonstrated significantly improved motor recovery at 1, 2, 5, and 8 weeks postinjury (week 8: IBB = 7 vs. 3; p = 0.01). Histologic analysis showed significantly reduced astroglial activation in the CAQK group (GFAP: treated = 0.1±0.01 vs. untreated = 0.7±0.2; p = 0.002) and increased axonal preservation (NFM: treated = 0.3±0.06 vs. untreated = 0.1±0.06; p = 0.03). In vitro, CAQK significantly enhanced neuronal network complexity compared with saline (p < 0.05).

CONCLUSIONS

CAQK treatment significantly improved motor outcomes compared with saline-only treatment. Ex vivo analysis of spinal cord tissue showed enhanced tissue recovery in CAQK-treated rats. In vitro, neuroprotection was evident in cells treated with CAQK. Overall, these findings support CAQK's potential as a targeted therapeutic candidate for SCI. (J Trauma Acute Care Surg 2026;00:000-000. Copyright © 2026 Wolters Kluwer Health, Inc. All rights reserved.).

STUDY TYPE: Basic Science.

Для цитирования: Castillo Jose A, Uppuluri Jay, Le Michael, Tran Taylor, Pivetti Christopher, Huang Kuan-Wei, Vatoofy Sina, Ratcliff Amanda, Dangan Andrei, Bannerman Solomon, Lee Maya, Shahin Mehrad, Loll Emma, Clark Kaitlin, Wang Aijun, Russo Rachel. The intravenous targeted nanopeptide, CAQK, is neuroprotective and improves motor function after spinal cord injury in rats.. The journal of trauma and acute care surgery. 2026. DOI: 10.1097/ta.0000000000005054.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.